{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T12:59:20Z","timestamp":1780750760975,"version":"3.54.1"},"publisher-location":"New York, NY","reference-count":13,"publisher":"Springer US","isbn-type":[{"value":"9781071647295","type":"print"},{"value":"9781071647301","type":"electronic"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1007\/978-1-0716-4730-1_33","type":"book-chapter","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T12:59:17Z","timestamp":1753707557000},"page":"487-499","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exon-Skipping Using Antisense Oligonucleotides for Laminin-Alpha2-Deficient Muscular Dystrophy"],"prefix":"10.1007","author":[{"given":"Eri","family":"Takeuchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaitra","family":"Sathyaprakash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hotake","family":"Takizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Motohashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Echigoya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshifumi","family":"Yokota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitsugu","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,29]]},"reference":[{"issue":"6","key":"33_CR1","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1172\/jci115244","volume":"87","author":"M Matsuo","year":"1991","unstructured":"Matsuo M, Masumura T, Nishio H, Nakajima T, Kitoh Y, Takumi T et al (1991) Exon skipping during splicing of dystrophin mRNA precursor due to an intraexon deletion in the dystrophin gene of Duchenne muscular dystrophy Kobe. J Clin Invest 87(6):2127\u20132131. https:\/\/doi.org\/10.1172\/jci115244","journal-title":"J Clin Invest"},{"issue":"25","key":"33_CR2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3000512","volume":"2","author":"MJ Wood","year":"2010","unstructured":"Wood MJ (2010) Toward an oligonucleotide therapy for Duchenne muscular dystrophy: a complex development challenge. Sci Transl Med 2(25):25ps15. https:\/\/doi.org\/10.1126\/scitranslmed.3000512","journal-title":"Sci Transl Med"},{"issue":"11","key":"33_CR3","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1038\/mt.2010.186","volume":"18","author":"Y Aoki","year":"2010","unstructured":"Aoki Y, Nakamura A, Yokota T, Saito T, Okazawa H, Nagata T et al (2010) In-frame dystrophin following exon 51-skipping improves muscle pathology and function in the exon 52-deficient mdx mouse. Mol Ther 18(11):1995\u20132005. https:\/\/doi.org\/10.1038\/mt.2010.186","journal-title":"Mol Ther"},{"issue":"34","key":"33_CR4","doi-asserted-by":"publisher","first-page":"13763","DOI":"10.1073\/pnas.1204638109","volume":"109","author":"Y Aoki","year":"2012","unstructured":"Aoki Y, Yokota T, Nagata T, Nakamura A, Tanihata J, Saito T et al (2012) Bodywide skipping of exons 45-55 in dystrophic mdx52 mice by systemic antisense delivery. Proc Natl Acad Sci USA 109(34):13763\u201313768. https:\/\/doi.org\/10.1073\/pnas.1204638109","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"33_CR5","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/ana.21627","volume":"65","author":"T Yokota","year":"2009","unstructured":"Yokota T, Lu QL, Partridge T, Kobayashi M, Nakamura A, Takeda S et al (2009) Efficacy of systemic morpholino exon-skipping in Duchenne dystrophy dogs. Ann Neurol 65(6):667\u2013676. https:\/\/doi.org\/10.1002\/ana.21627","journal-title":"Ann Neurol"},{"issue":"1","key":"33_CR6","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1073\/pnas.0406700102","volume":"102","author":"QL Lu","year":"2005","unstructured":"Lu QL, Rabinowitz A, Chen YC, Yokota T, Yin H, Alter J et al (2005) Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal muscles. Proc Natl Acad Sci USA 102(1):198\u2013203. https:\/\/doi.org\/10.1073\/pnas.0406700102","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"33_CR7","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/nrneurol.2016.180","volume":"12","author":"JJ Dowling","year":"2016","unstructured":"Dowling JJ (2016) Eteplirsen therapy for Duchenne muscular dystrophy: skipping to the front of the line. Nat Rev Neurol 12(12):675\u2013676. https:\/\/doi.org\/10.1038\/nrneurol.2016.180","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"33_CR8","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/s0014-5793(97)01007-7","volume":"415","author":"Y Miyagoe","year":"1997","unstructured":"Miyagoe Y, Hanaoka K, Nonaka I, Hayasaka M, Nabeshima Y, Arahata K et al (1997) Laminin alpha2 chain-null mutant mice by targeted disruption of the Lama2 gene: a new model of merosin (laminin 2)-deficient congenital muscular dystrophy. FEBS Lett 415(1):33\u201339. https:\/\/doi.org\/10.1016\/s0014-5793(97)01007-7","journal-title":"FEBS Lett"},{"key":"33_CR9","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3389\/fnmol.2020.00059","volume":"13","author":"KI Gawlik","year":"2020","unstructured":"Gawlik KI, Durbeej M (2020) A family of Laminin \u03b12 chain-deficient mouse mutants: advancing the research on LAMA2-CMD. Front Mol Neurosci 13:59. https:\/\/doi.org\/10.3389\/fnmol.2020.00059","journal-title":"Front Mol Neurosci"},{"issue":"3","key":"33_CR10","doi-asserted-by":"publisher","DOI":"10.1212\/nxg.0000000000200148","volume":"10","author":"AR Foley","year":"2024","unstructured":"Foley AR, Yun P, Leach ME, Neuhaus SB, Averion GV, Hu Y et al (2024) Phase 1 open-label study of Omigapil in patients with LAMA2- or COL6-related dystrophy. Neurol Genet 10(3):e200148. https:\/\/doi.org\/10.1212\/nxg.0000000000200148","journal-title":"Neurol Genet"},{"key":"33_CR11","doi-asserted-by":"publisher","first-page":"113","DOI":"10.2147\/tacg.S187481","volume":"12","author":"Q Nguyen","year":"2019","unstructured":"Nguyen Q, Lim KRQ, Yokota T (2019) Current understanding and treatment of cardiac and skeletal muscle pathology in laminin-\u03b12 chain-deficient congenital muscular dystrophy. Appl Clin Genet 12:113\u2013130. https:\/\/doi.org\/10.2147\/tacg.S187481","journal-title":"Appl Clin Genet"},{"issue":"24","key":"33_CR12","doi-asserted-by":"publisher","first-page":"4914","DOI":"10.1093\/hmg\/ddt341","volume":"22","author":"Y Aoki","year":"2013","unstructured":"Aoki Y, Nagata T, Yokota T, Nakamura A, Wood MJ, Partridge T et al (2013) Highly efficient in vivo delivery of PMO into regenerating myotubes and rescue in laminin-\u03b12 chain-null congenital muscular dystrophy mice. Hum Mol Genet 22(24):4914\u20134928. https:\/\/doi.org\/10.1093\/hmg\/ddt341","journal-title":"Hum Mol Genet"},{"issue":"13","key":"33_CR13","doi-asserted-by":"publisher","first-page":"3568","DOI":"10.1093\/nar\/gkg616","volume":"31","author":"L Cartegni","year":"2003","unstructured":"Cartegni L, Wang J, Zhu Z, Zhang MQ, Krainer AR (2003) ESEfinder: a web resource to identify exonic splicing enhancers. Nucleic Acids Res 31(13):3568\u20133571. https:\/\/doi.org\/10.1093\/nar\/gkg616","journal-title":"Nucleic Acids Res"}],"container-title":["Methods in Molecular Biology","Exon Skipping and Inclusion Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-4730-1_33","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T12:06:05Z","timestamp":1780747565000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-4730-1_33"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9781071647295","9781071647301"],"references-count":13,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-4730-1_33","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"29 July 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}